Chaperone therapy: protective against Parkinson's disease?

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1326, 2002-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hormone replacement therapy: not protective against heart disease?

By  

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Estrogens: protective against Alzheimer's disease?

By  

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Pramipexole for initial therapy of early Parkinson's disease?

By  

Inpharma, Vol. 1, Iss. 1261, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

GDNF gene therapy: potent benefits in Parkinson's disease?

By  

Inpharma, Vol. 1, Iss. 1266, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

When Should Levodopa Therapy be Initiated in Patients with Parkinson's Disease?

By Halkias Irene A.C.   Haq Ihtsham   Huang Zhigao   Fernandez Hubert H.  

Drugs & Aging, Vol. 24, Iss. 4, 2007-01 ,pp. : 261-273

Adis International

Access to resources Recommend Favorite